Real World Evidence (RWE) plays a critical role across multiple pharma processes, including drug development, regulatory decision-making, precision medicine and health economics, providing valuable insights from actual clinical practice. In order to leverage these data effectively and make informed decisions, sponsors need to be aware of the types of data that are available and the challenges faced within as well as the differences between RWE and clinical trial data and how they can complement each other. In this webinar, we will introduce RWE and discuss the challenges and strengths one might encounter in this space.
This webinar is part of our three-part online series. To book a place on upcoming sessions of this series, click here.
Speakers:
- Tasos Mangelis, Principal Data Scientist
- Moderator: Alice Wang, Associate Director of Data Science
Learning Points:
- Harnessing Real World Data (RWD) to generate RWE for regulatory studies.
- Leveraging RWE alongside Clinical Trial Data.
- Deploying RWE to make data driven decisions – a real application.
Complete the form below to access the recording and slides.
